TORONTO--(BUSINESS WIRE)--Feb. 4, 2008--Biovail Corporation (NYSE: BVF)(TSX: BVF) today announced that the Company will present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference at the Grand Hyatt Hotel in New York City.
Biovail's presentation is scheduled for Wednesday, February 6, 2008 at 3:20 p.m. EST. A live and archived Webcast, in addition to presentation slides, will be available on the Investor Relations page of Biovail's Web site at www.biovail.com.
About Biovail Corporation
Biovail Corporation is a specialty pharmaceutical company, engaged in the formulation, clinical testing, registration, manufacture and commercialization of pharmaceutical products utilizing advanced drug-delivery technologies. For more information about Biovail, visit the Company's Web site at www.biovail.com.
For further information, please contact Nelson F. Isabel at 905-286-3000 or send inquiries to [email protected].
CONTACT: Biovail Corporation
Nelson F. Isabel, 905-286-3000
VP, Investor Relations & Corporate Communications
